清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Comorbidity and in-hospital mortality in peritoneal dialysis patients: data of the Emilia Romagna region of Italy.

共病 腹膜透析 医学 透析 血液透析 内科学 查尔森共病指数 队列 重症监护医学 急诊医学
作者
Fabio Fabbian,Alfredo De Giorgi,Francesco Ferrara,Gaetano Alfano,Giacomo Mori,A Di Maria,Marialaura Frisina,Maddalena Veronesi,Alda Storari,Gabriele Donati
出处
期刊:PubMed 卷期号:27 (14): 6867-6875 被引量:1
标识
DOI:10.26355/eurrev_202307_33158
摘要

Kidney failure increases in-hospital mortality (IHM); however, comorbidity is crucial for predicting mortality in dialysis patients. Our aim was to evaluate the impact of comorbidity, assessed by modified Elixhauser index (mEI), Charlson Comorbidity Index (CCI), and age-adjusted CCI, on IHM in a cohort of peritoneal dialysis patients admitted to hospitals of the Emilia Romagna region (ERR) of Italy.All hospital admissions of peritoneal dialysis patients recorded between 2007 and 2021 in the ERR database were analyzed. The International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) was used for detecting diagnoses and procedures, and the inclusion criterion was code 5498. Comorbidity burden was evaluated by three different scores, and hemodialysis (HD) treatment need was considered. IHM was our outcome.During the 15 years of the study, 3,242 hospitalized peritoneal dialysis patients (62.7% males) were evaluated. Mean age was 62.8±20.6 years, 9.6% underwent HD, and IHM was 5.9% (n=192). IHM mortality was stable throughout the study period. Deceased subjects were older, were hospitalized longer, had a higher comorbidity burden, and had a higher percentage of HD treatment needs than survivors. Age, male sex, comorbidity burden, and HD treatment were predictors of IHM. Receiver operating characteristics (ROC) analysis confirmed the impact of comorbidity burden on IHM, especially when age was considered.We conclude that in male, elderly hospitalized peritoneal dialysis patients with failing dialysis technique, comorbidity burden should be considered being a predictor of IHM.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小白完成签到 ,获得积分10
11秒前
老石完成签到 ,获得积分10
35秒前
紫熊发布了新的文献求助30
43秒前
玛卡巴卡爱吃饭完成签到 ,获得积分10
53秒前
1分钟前
走啊走完成签到,获得积分0
1分钟前
1分钟前
woxinyouyou完成签到,获得积分10
1分钟前
阔达冰香完成签到 ,获得积分10
1分钟前
STEMOS完成签到 ,获得积分10
2分钟前
科研通AI2S应助科研通管家采纳,获得10
3分钟前
3分钟前
3分钟前
紫熊完成签到,获得积分10
4分钟前
4分钟前
ptyz霍建华发布了新的文献求助30
4分钟前
4分钟前
TTRRCEB发布了新的文献求助10
5分钟前
深情安青应助科研通管家采纳,获得10
5分钟前
乐乐应助科研通管家采纳,获得10
5分钟前
5分钟前
5分钟前
coolulu发布了新的文献求助10
5分钟前
大医仁心完成签到 ,获得积分10
5分钟前
6分钟前
6分钟前
科研通AI2S应助科研通管家采纳,获得10
7分钟前
小猫蛋堡完成签到,获得积分10
8分钟前
Hello应助小猫蛋堡采纳,获得10
8分钟前
彭晓雅完成签到,获得积分10
8分钟前
8分钟前
彭晓雅发布了新的文献求助80
8分钟前
123发布了新的文献求助20
8分钟前
8分钟前
科研通AI6.3应助彭晓雅采纳,获得80
9分钟前
三心草完成签到 ,获得积分10
9分钟前
10分钟前
hesse发布了新的文献求助10
10分钟前
10分钟前
wang完成签到,获得积分10
10分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Burger's Medicinal Chemistry, Drug Discovery and Development, Volumes 1 - 8, 8 Volume Set, 8th Edition 1800
Cronologia da história de Macau 1600
Netter collection Volume 9 Part I upper digestive tract及Part III Liver Biliary Pancreas 3rd 2024 的超高清PDF,大小约几百兆,不是几十兆版本的 1050
Current concept for improving treatment of prostate cancer based on combination of LH-RH agonists with other agents 1000
Research Handbook on the Law of the Sea 1000
Contemporary Debates in Epistemology (3rd Edition) 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 计算机科学 化学工程 生物化学 物理 复合材料 内科学 催化作用 物理化学 光电子学 细胞生物学 基因 电极 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6166072
求助须知:如何正确求助?哪些是违规求助? 7993591
关于积分的说明 16621056
捐赠科研通 5272192
什么是DOI,文献DOI怎么找? 2812821
邀请新用户注册赠送积分活动 1792757
关于科研通互助平台的介绍 1658841